XML 27 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities:      
Net loss $ (9,928) $ (89,322) $ (201,326)
Less: net (income) loss from discontinued operations, net of tax (24,028) 33,610 83,767
Net loss from continuing operations (33,956) (55,712) (117,559)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:      
Depreciation and amortization 19,146 20,333 22,655
Unrealized (gain) loss on foreign currency (872) (1,088) 5,389
Stock-based compensation 5,531 5,282 18,580
Change in fair value of warrants 1,372 11 (4,543)
Change in fair value of derivative liability 0 (180) (4,695)
Amortization of debt discount and deferred issuance costs 6,086 1,766 1,535
Deferred income tax (304) 3,236 (1,594)
Gain on disposition of assets (1,250) (175) (500)
Loss (gain) on investment 0 3,500 (1,260)
Provision for doubtful accounts (385) (581) 785
Impairment expense 0 0 50,546
Noncash lease expense 18,123 20,017 19,870
Changes in operating assets and liabilities:      
Accounts receivable 25,816 40,568 27,462
Prepaid expenses and other current assets and prepaid expenses and other assets 6,124 4,577 3,508
Accounts payable (30,464) 19,149 11,179
Accrued compensation (474) (18,257) (5,440)
Accrued expenses, other current liabilities and other liabilities 3,288 (12,619) (2,841)
Lease liabilities (22,222) (23,421) (23,249)
Deferred revenue (1,245) (7,098) 7,154
Cash (used in) provided by operating activities from continuing operations (5,686) (692) 6,982
Net cash used in operating activities from discontinued operations (14,993) (5,411) (14,839)
Net cash flow used in operating activities (20,679) (6,103) (7,857)
Investing activities:      
Capital expenditures (691) (964) (5,424)
Capitalization of internal-use software (12,078) (13,934) (12,361)
Proceeds from sale of asset 350 175 500
Cash used in investing activities from continuing operations (12,419) (14,723) (17,285)
Cash provided by investing activities from discontinued operations 191,075 0 0
Cash provided by (used in) investing activities 178,656 (14,723) (17,285)
Financing activities:      
Payment for shares withheld for employee taxes (394) (451) (1,698)
Deferred reverse recapitalization costs 0 0 (585)
Proceeds from exercise of stock options 1 29 459
Proceeds from the issuance of common stock in connection with the at-the-market offering, net of issuance costs 1,030 902 0
Borrowings on Revolving Credit Facility 0 2,128 5,000
Payments on Revolving Credit Facility (33,837) (1,796) 0
Payment on Convertible Notes (120,000) 0 0
Payment of early termination fee for Revolving Credit Facility (500) 0 0
Payment of consent solicitation fee for Convertible Notes (900) 0 0
Cash (used in) provided by financing activities (154,600) 812 3,176
Effect of currency translation on cash and cash equivalents (366) (123) (1,993)
Net increase (decrease) in cash and cash equivalents 3,011 (20,137) (23,959)
Cash and cash equivalents at beginning of year 35,637 55,774 79,733
Cash and cash equivalents at end of year $ 38,648 $ 35,637 $ 55,774